CDK5 and Alzheimer disease: Importantly, aberrant Cdk5 activity and dysregulation of DBN have been linked to synaptic dysfunction in AD, suggesting that similar phosphorylation-dependent mechanisms may be disrupted in disease (Pao and Tsai, 2021; Shah and Rossie, 2017).